Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria.
<h4>Background</h4> <p>Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) variants are encoded by var genes and mediate pathogenic cytoadhesion and antigenic variation in malaria. PfEMP1s can be broadly divided into three principal groups (A, B and C) and they contain c...
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2016
|
| _version_ | 1826266714745077760 |
|---|---|
| author | Duffy, M Noviyanti, R Tsuboi, T Feng, Z Trianty, L Sebayang, B Takashima, E Sumardy, F Lampah, D Turner, L Lavstsen, T Fowkes, F Siba, P Rogerson, S Theander, T Marfurt, J Price, R Anstey, N Brown, G Papenfuss, A |
| author_facet | Duffy, M Noviyanti, R Tsuboi, T Feng, Z Trianty, L Sebayang, B Takashima, E Sumardy, F Lampah, D Turner, L Lavstsen, T Fowkes, F Siba, P Rogerson, S Theander, T Marfurt, J Price, R Anstey, N Brown, G Papenfuss, A |
| author_sort | Duffy, M |
| collection | OXFORD |
| description | <h4>Background</h4> <p>Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) variants are encoded by var genes and mediate pathogenic cytoadhesion and antigenic variation in malaria. PfEMP1s can be broadly divided into three principal groups (A, B and C) and they contain conserved arrangements of functional domains called domain cassettes. Despite their tremendous diversity there is compelling evidence that a restricted subset of PfEMP1s is expressed in severe disease. In this study antibodies from patients with severe and uncomplicated malaria were compared for differences in reactivity with a range of PfEMP1s to determine whether antibodies to particular PfEMP1 domains were associated with severe or uncomplicated malaria.</p> <h4>Methods</h4> <p>Parts of expressed var genes in a severe malaria patient were identified by RNAseq and several of these partial PfEMP1 domains were expressed together with others from laboratory isolates. Antibodies from Papuan patients to these parts of multiple PfEMP1 proteins were measured.</p> <h4>Results</h4> <p>Patients with uncomplicated malaria were more likely to have antibodies that recognized PfEMP1 of Group C type and recognized a broader repertoire of group A and B PfEMP1s than patients with severe malaria.</p> <h4>Conclusion</h4> <p>These data suggest that exposure to a broad range of group A and B PfEMP1s is associated with protection from severe disease in Papua, Indonesia.</p> |
| first_indexed | 2024-03-06T20:43:10Z |
| format | Journal article |
| id | oxford-uuid:34efa94e-5402-4c42-848f-b18021a345e0 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:43:10Z |
| publishDate | 2016 |
| publisher | BioMed Central |
| record_format | dspace |
| spelling | oxford-uuid:34efa94e-5402-4c42-848f-b18021a345e02022-03-26T13:29:12ZDifferences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:34efa94e-5402-4c42-848f-b18021a345e0EnglishSymplectic Elements at OxfordBioMed Central2016Duffy, MNoviyanti, RTsuboi, TFeng, ZTrianty, LSebayang, BTakashima, ESumardy, FLampah, DTurner, LLavstsen, TFowkes, FSiba, PRogerson, STheander, TMarfurt, JPrice, RAnstey, NBrown, GPapenfuss, A <h4>Background</h4> <p>Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) variants are encoded by var genes and mediate pathogenic cytoadhesion and antigenic variation in malaria. PfEMP1s can be broadly divided into three principal groups (A, B and C) and they contain conserved arrangements of functional domains called domain cassettes. Despite their tremendous diversity there is compelling evidence that a restricted subset of PfEMP1s is expressed in severe disease. In this study antibodies from patients with severe and uncomplicated malaria were compared for differences in reactivity with a range of PfEMP1s to determine whether antibodies to particular PfEMP1 domains were associated with severe or uncomplicated malaria.</p> <h4>Methods</h4> <p>Parts of expressed var genes in a severe malaria patient were identified by RNAseq and several of these partial PfEMP1 domains were expressed together with others from laboratory isolates. Antibodies from Papuan patients to these parts of multiple PfEMP1 proteins were measured.</p> <h4>Results</h4> <p>Patients with uncomplicated malaria were more likely to have antibodies that recognized PfEMP1 of Group C type and recognized a broader repertoire of group A and B PfEMP1s than patients with severe malaria.</p> <h4>Conclusion</h4> <p>These data suggest that exposure to a broad range of group A and B PfEMP1s is associated with protection from severe disease in Papua, Indonesia.</p> |
| spellingShingle | Duffy, M Noviyanti, R Tsuboi, T Feng, Z Trianty, L Sebayang, B Takashima, E Sumardy, F Lampah, D Turner, L Lavstsen, T Fowkes, F Siba, P Rogerson, S Theander, T Marfurt, J Price, R Anstey, N Brown, G Papenfuss, A Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria. |
| title | Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria. |
| title_full | Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria. |
| title_fullStr | Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria. |
| title_full_unstemmed | Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria. |
| title_short | Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria. |
| title_sort | differences in pfemp1s recognized by antibodies from patients with uncomplicated or severe malaria |
| work_keys_str_mv | AT duffym differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT noviyantir differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT tsuboit differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT fengz differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT triantyl differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT sebayangb differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT takashimae differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT sumardyf differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT lampahd differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT turnerl differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT lavstsent differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT fowkesf differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT sibap differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT rogersons differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT theandert differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT marfurtj differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT pricer differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT ansteyn differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT browng differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria AT papenfussa differencesinpfemp1srecognizedbyantibodiesfrompatientswithuncomplicatedorseveremalaria |